Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: A randomized controlled trial

AIMS/INTRODUCTION: We compared the satisfaction levels of patients with type 2 diabetes undergoing combination therapy with lixisenatide (LIX) and basal insulin with that of patients undergoing multiple daily insulin injection (MDI) therapy. MATERIALS AND METHODS: The study was a 12‐week open‐label,...

Descripción completa

Detalles Bibliográficos
Autores principales: Miya, Aika, Nakamura, Akinobu, Miyoshi, Hideaki, Cho, Kyu Yong, Nagai, So, Kurihara, Yoshio, Aoki, Shin, Taguri, Masataka, Terauchi, Yasuo, Atsumi, Tatsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754530/
https://www.ncbi.nlm.nih.gov/pubmed/28296201
http://dx.doi.org/10.1111/jdi.12654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5754530/
https://www.ncbi.nlm.nih.gov/pubmed/28296201
http://dx.doi.org/10.1111/jdi.12654

Ejemplares similares